These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3471273)

  • 1. Serum CA 125 in epithelial ovarian cancer. A longitudinal study.
    Brioschi PA; Irion O; Bischof P; Bader M; Forni M; Krauer F
    Br J Obstet Gynaecol; 1987 Mar; 94(3):196-201. PubMed ID: 3471273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence.
    Schilthuis MS; Aalders JG; Bouma J; Kooi H; Fleuren GJ; Willemse PH; De Bruijn HW
    Br J Obstet Gynaecol; 1987 Mar; 94(3):202-7. PubMed ID: 3471274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125].
    Sevelda P; Wagner G
    Wien Klin Wochenschr; 1987 Nov; 99(21):768-70. PubMed ID: 3480655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAM26, CAM29 and mucin-like carcinoma associated antigen in epithelial ovarian cancer.
    Ferdeghini M; Gadducci A; dell'Hoste M; Prontera C; Ceccarini T; Rispoli G; Bianchi R; Fioretti P
    Eur J Gynaecol Oncol; 1990; 11(5):395-401. PubMed ID: 1965803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experiences with the tumor markers Ca 125 and plasma ribonuclease in ovarian cancer].
    Lücke R; Benz R; Kraus H
    Geburtshilfe Frauenheilkd; 1987 Dec; 47(12):846-9. PubMed ID: 3481339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
    Cruickshank DJ; Fullerton WT; Klopper A
    Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous measurement of CA 125, CA 19-9, tissue polypeptide antigen, and immunosuppressive acidic protein to predict recurrence of ovarian cancer.
    Kamiya N; Mizuno K; Kawai M; Kano T; Furuhashi Y; Tomoda Y
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):417-21. PubMed ID: 2381619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CA 125 levels in patients with endometriosis: changes in CA 125 levels during menstruation.
    Masahashi T; Matsuzawa K; Ohsawa M; Narita O; Asai T; Ishihara M
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):328-31. PubMed ID: 3165507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
    Crombach G; Zippel HH; Würz H
    Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of serum sialosyl-Tn antigen levels in comparison with CA 125 levels in gynecologic cancers.
    Ryuko K; Iwanari O; Nakayama S; Iida K; Kitao M
    Cancer; 1992 May; 69(9):2368-78. PubMed ID: 1562985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cancer antigen 125 (CA 125) in the management of ovarian epithelial carcinomas.
    Altaras MM; Goldberg GL; Levin W; Bloch B; Darge L; Smith JA
    Gynecol Oncol; 1988 May; 30(1):26-34. PubMed ID: 2452770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
    Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
    Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative serum CA-125 levels in patients with surgical stage I invasive ovarian adenocarcinoma.
    Mann WJ; Patsner B; Cohen H; Loesch M
    J Natl Cancer Inst; 1988 Apr; 80(3):208-9. PubMed ID: 3162284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Prontera C; Moretti L; Pellagatta L; Bianchi R; Fioretti P
    J Nucl Biol Med (1991); 1991; 35(1):33-7. PubMed ID: 1657201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA 125 in gynecologic practice.
    Malkasian GD; Podratz KC; Stanhope CR; Ritts RE; Zurawski VR
    Am J Obstet Gynecol; 1986 Sep; 155(3):515-8. PubMed ID: 2428248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CA-125 in the evaluation of benign adnexal cysts.
    Pittaway DE; Fayez JA; Douglas JW
    Am J Obstet Gynecol; 1987 Dec; 157(6):1426-8. PubMed ID: 3480690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
    Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
    Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum level of the tumor marker CA 125 in ovarian pathology].
    Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
    Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Ca 125 as tumor marker in ovarian carcinoma.
    Krebs HB; Goplerud DR; Kilpatrick SJ; Myers MB; Hunt A
    Obstet Gynecol; 1986 Apr; 67(4):473-7. PubMed ID: 3008052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.